IDEXX LaboratoriesFRA:IX1 -0.19%96 OCF Margin % is 23.34% as of Mar. 2026, which is 10% above its 10-year median of 21.30. GuruFocus rates FRA:IX1 with a GF Score™ of 96/100 and a GF Value™ of €544.17 (Modestly Undervalued). Among 204 Medical Diagnostics & Research companies, IDEXX Laboratories ranks better than 90.2% on this metric.
The historical rank and industry rank for IDEXX Laboratories's OCF Margin % or its related term are showing as below:
FRA:IX1'
s OCF Margin % Range Over the Past 10 Years
Min: 16.13 Med: 21.3 Max: 27.46
Current: 27.16
During the past 13 years, the highest OCF Margin % of IDEXX Laboratories was 27.46%. The lowest was 16.13%. And the median was 21.30%.
FRA:IX1's OCF Margin % is ranked better than 90.2% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs FRA:IX1: 27.16
IDEXX Laboratories OCF Margin % Related Terms
IDEXX Laboratories OCF Margin % Historical Data
* Premium members only.
The historical data trend for IDEXX Laboratories's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, IDEXX Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's OCF Margin % distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories (FRA:IX1) has a OCF Margin % of 23.34% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IDEXX Laboratories and its competitors. This is 10% above median its historical median of 21.30. Over the past decade, IDEXX Laboratories' OCF Margin % has ranged from 16.13 to 27.46. According to the industry distribution chart, IDEXX Laboratories ranks #20 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 9.8%.
Is IDEXX Laboratories' OCF Margin % too high?
IDEXX Laboratories' current OCF Margin % of 23.34% is 10% above median its 10-year median of 21.30. Over the past 10 years, this metric has ranged from a low of 16.13 to a high of 27.46. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. IDEXX Laboratories' value of 23.34% is 390.9% above this industry median. Based on the distribution chart, IDEXX Laboratories ranks #20 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' OCF Margin % compare to A and WAT?
According to the Medical Diagnostics & Research industry distribution chart, IDEXX Laboratories ranks #20 out of 204 companies for OCF Margin %. This places IDEXX Laboratories in the top 10% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 4.76. IDEXX Laboratories' value of 23.34% is 390.9% above this benchmark. Historically, IDEXX Laboratories' own OCF Margin % has ranged from 16.13 to 27.46 over the past decade. While the company's 10-year median is 21.30 vs. the industry median of 4.76, IDEXX Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDEXX Laboratories's current OCF Margin % of 23.34% is 390.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IDEXX Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEXX Laboratories's current OCF Margin % is 23.34%, which is 10% above median its own 10-year median of 21.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (FRA:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €544.17, compared to a current price of €473.80 — trading 12.9% below its estimated fair value. The current OCF Margin % is 23.34%, which is 10% above median its 10-year median of 21.30 and 390.9% above the Medical Diagnostics & Research industry median of 4.76. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For IDEXX Laboratories (FRA:IX1), the current OCF Margin % is 23.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEXX Laboratories (FRA:IX1) Overvalued in 2026?
Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued.
The current stock price of €473.80 is trading 12.9% below its estimated GF Value™ of €544.17.
GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.
Key valuation signals for FRA:IX1:
OCF Margin %: 23.34% (10% above median its 10-year median of 21.30)
GF Value™: €544.17 vs. price of €473.80 (12.9% below fair value)
Industry Position: 390.9% above the Medical Diagnostics & Research median (#20 of 204)
No single metric tells the full story. See the FRA:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score
Get the complete analysis for FRA:IX1
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IX1 has been successfully added to your 
